S&P 500 7,674.48 −1.07%
Nasdaq 26,157.61 −2.04%
S&P/TSX 35,943.02 −1.05%
Apple 345.71 +0.50%
Nvidia 213.46 −3.83%
Microsoft 526.19 −1.27%
Shopify 239.84 −2.08%
Royal Bank 282.81 −0.29%
CAD/USD 0.7131 +0.31%
LIVE · 12:05 ET
Market ClerkRecap
Thu Oct 22 · markets open6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

LGND

LIGAND PHARMACEUTICALS INC
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
314.01
−0.77 −0.24%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $6.3BP/E 33.4DIV YIELD —FCF YIELD 2.10%REV TTM $290.5M +54.9%NET INCOME $197.2MNET DEBT $119.9M52W 181.65 – 322.61SEC XBRL · TTM TO Invalid Date

What LGND had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Sep 24Other eventReg FD disclosureSep 24open on EDGAR ↗
Sep 22Reg FD disclosureSep 22open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch LGND. Know when insiders buy.
One email the day a filing lands. Free.